Showing results (811-820 of 1,024) with videos related to

Sort By:
Pageof 103
Oral Oncology|April 20, 2012
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neckCesar A Perez, Hunho Song, Luis E Raez, et al.
Mayo Clinic Proceedings|December 20, 2015
Post-September 11, 2001, Incidence of Systemic Autoimmune Diseases in World Trade Center-Exposed Firefighters and Emergency Medical Service WorkersMayris P Webber, William Moir, Cynthia S Crowson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2012
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiationT Y Seiwert, T Darga, D Haraf, et al.
American Journal of Respiratory and Critical Care Medicine|November 19, 2011
Metabolic syndrome biomarkers predict lung function impairment: a nested case-control studyBushra Naveed, Michael D Weiden, Sophia Kwon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 5, 2011
Psychometric properties of instruments to measure the quality of end-of-life care and dying for long-term care residents with dementiaMirjam C van Soest-Poortvliet, Jenny T van der Steen, Sheryl Zimmerman, et al.
Journal for Immunotherapy of Cancer|December 6, 2019
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumorsEzra E W Cohen, Michael J Pishvaian, Dale R Shepard, et al.
International Journal of Environmental Research and Public Health|December 9, 2020
Factors Predicting Treatment of World Trade Center-Related Lung Injury: A Longitudinal Cohort StudyBarbara Putman, Lies Lahousse, David G Goldfarb, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2022
Somatic 9p24.1 alterations in HPV- head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activityXin Zhao, Ezra E W Cohen, William N William, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Linked CD4 + /CD8 + T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regressionJoseph S Dolina, Joey Lee, Spencer E Brightman, et al.
Science Advances|May 4, 2022
Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domainMatthew D Gray, Junli Feng, Connor E Weidle, et al.
Pageof 103